1. Gemmell Ch. Activation of platelets by in vitro whole blood contact with materials: increases in microparticle, procoagulant activity and soluble P – selectin blood levels. J Biomater Sci Polym Ed 2001; 12: 933-943.
2. Gullikson H. Platelet storage media. Transfus Apher Sci 2001; 24: 241–244.
3. Runkel S, Bach J, Anders C, et al. The impact of two whole blood inline filters on markers of coagulation, complement and cell activation. Vox Sanq 2005; 88: 17-21.
4. Seghatchian J, Krailadsiri P. The platelet storage lesion. Transfus Med Rev 1997; 11: 130-144.
5. Solheim BG, Flesland O, Seghatchian J, et al. Clinical implications of red blood cell and platelet storage lesions: an overview. Transfus Apher Sci 2004; 31: 185-189.
6. Bessos H, Seghatchian J. Red cell storage lesions: The potential impact of storage-induced CD47 decline on immunomodulation and the survival of leucofiltered red cells. Transf Apher Sci 2005; 32: 227-232.
7. Curvers J, van Pampus ECM, Feijge MAH, et al. Decreased responsiveness and development of activation markers of PLTs stored in plasma. Transfusion 2004; 44: 49-58.
8. Perrotta PL, Perrotta ChL, Snyder EL. Apoptotic activity in stored human platelets. Transfusion 2003; 43: 526-535.
9. Dzik WH. Apoptosis, TGF beta and transfusion-related immunosupresion: Biologic versus clinical efects. Transf Apher Sci 2003; 29: 127-129.
10. Bertino AM, Qi XQ, Xia Y, et al. Apoptotic markers are increased in platelets stored at 37 °C. Transfusion 2003; 43: 857-866.
11. Lang F, Foller M, Lang KS, at al. Ion channels in cell proliferation and apoptotic cell death. J Membrane Bioll 2005; 205: 147-157.
12. Leitner GC, Stohlawetz PJ, Stiegler G, et al. Quality of packed red blood cells and platelet concentrates by multicomponent collection using the MCS Plus device. Journal of Clinical Apheresis 2003; 18: 21-25.
13. Wolfe LC. The membrane and the lesions of storage in preserved red cells. Transfusion 1985; 25: 185-202.
14. Gutensohn K, Geidel K, Kroeger N, et al. Platelet function testing in apheresis products: flow cytometric, resonance thrombographic (RTG) and rotaional thrombelastographic (roTEG) analyses. Transfus Apher Sci 2002; 26: 147-155.
15. Hess JR. Red cell changes during storage. Transfus Apher Sci 2010; 43: 51-59.
16. Dijkstra-Tiekstra MJ, Pietersz RNI, Huijgens PC. Correlation between the extent of platelet activation in platelet concentrates and in vitro and in vivo parameters. Vox Sanq 2004; 87: 257-263.
17. Krailadsiri P, Seghatchian P, Amiral J, et al. Annexin V, a new marker of platelet storage lesion: correlation with dMPV. Transfus Sci 1997; 18: 223-226.
18. Krailadsiri P, Seghatchian J. Effect of processing and storage on platelet activation, cellular injury and microvesiculation. Transfus Apher Sci 2001, 24: 237-238.
19. Seghatchian J, Krailadsiri P. Red cell storage lesion assesed by the levels of potassium, hemoglobin and annexin V in supernatant. Transfus Apher Sci 2002; 26: 121-127.
20. Tzima E, Walker JH. Platelet annexin V: the ins and outs. Platelets 2000; 11: 245 – 251.
21. Gibson JG, Murphy WP, Scheitlin WA, et al. The influence of intracellular factors involved in the collection of blood in ACD on maintenance of red cell viability during refrigerated storage. Am J Clin Pathol 1956; 26: 858-873.
22. Llohn A, Vetlesen A, Fagerhol MK, et al. The effect of pre-storage cooling on 2,3-DPG levels in red cells stored in SAG-M. Transfus Apher Sci 2005; 33: 113-118.
23. Holme S, Elfath MD, Whitley P. Evaluation of in vivo and in vitro quality of apheresis- collected RBC stored for 42 days. Vox Sanq 1998; 75: 212-217.
24. Korte D, Korsten HGH, Verhoeven AJ. Prolonged maintenance of 2,3-diphosphoglycerate acid and adenosine triphosphare in red blood cells during storage. Transfusion 2008; 48: 1081-1089.
25. Kim-Shapiro DB, Lee J, Gladwin MT. Storage lesion: role of red blood cell breakdown. Transfusion 2011; 51: 844-851.
26. Annis AM, Sparrow RL. Expression of CD47 (integrin associated protein) decreases on red blood cells during storage. Transfus Apher Sci 2002; 27: 233-233.
27. Sparrow RL, Healey G, Patton KA, et al. Red blood cell age determines the impact of storage and leukocyte burden on cell adhesion molecules, glycophorin A and the release of annexin V. Transfus Apher Sci 2006; 34: 15-23.
28. Loudová M, Krejsek J, Kopecký O, et al. Cytoimunofluorometrie a její využití v detekci aktivované destičky. Vnitř lék 2001; 47: 175-180.
29. Holme S, Sweeney S, et al. The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss in vivo viability. Transfusion 1997; 37: 2-17.
30. Shrivastava M. The platelet storage lesion. Transfus Apher Sci 2009; 41: 105-113.
31. Perseghin P, Mascaretti L, Speranza T, et al. Platelet activation during plasma-reduced multicomponent PLT collection: a comparison between COBE Trima and Spectra LRS turbo cell separators. Transfusion 2004; 44: 125-130.
32. Seghatchian MJ, Wadhwa M, Thorpe R. Cytokines in platelet concentrates: A comparison of apheresis platelet (Haemonetics) and filtered and unfiltered pooled buffy-coat derived platelet concentrates. Transfus Sci 1997; 18: 103-107.
33. Lin SJ, Tzeng CH, Hao HY, et al. Cytokine release in febrile non-haemolytic red cell transfusion reactions. Vox Sanq 2002; 82: 156-160.
34. Wadhwa M, Seghatchian MJ, Dilger P, et al. Cytokine accumulation in stored red cell concentrates: effect of buffy-coat removal and leucoreduction. Transfus Sci 2000; 23: 7-16.
35. Seghatchian J. Platelet storage lesion: An update on the impact of various leukoreduction processes on the biological response modifiers. Transfus Apher Sci 2006; 34: 125-130.
36. Seghatchian J, Krailadsiri P, Dilger P, et al. Cytokines as quality indicators of leucoreduced red cell concentrates. Transfus Apher Sci 2002; 26: 43-46.
37. Wadhwa M, Krailadsiri P, Dilger P, et al. Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates. Vox Sanq 2002; 83: 125-136.
38. Guide to the preparation, use and quality assurance of blood components. 12th ed. Strasburg, Council of Europe Publishing, 2006.
39. Ali SF. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods. Transfus Apher Sci 2011; 44: 11-13.
40. Vetlesen A, Mirlashari MR, Ezligini F, Kjeldsen-Kragh J. Evaluation of platelets activation and cytokine release during storage of platelet concentrates processed from buffy-coats either manually or by the automated OrbiSac system. Transfusion 2007; 47: 126-132.
41. Zhang JG, Carter JC, Culibrk B, et al. Buffy coat platelet variables and metabolism during storage in additive solutions or plasma. Transfusion 2008; 48: 847-856.
42. Diedrich B, Sandgren P, Jansson B, et al. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solutions. Vox Sanq 2008; 94: 96-102.
43. Gullikson H, AuBuchon JP, Vesterinen M, et al. Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium. Vox Sanq 2002; 82: 131-136.
44. Cardigan R, Sutherland J, Garwood M, et al. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PAS II or 100% plasma in three different storage bags. Vox Sanq 2008; 94: 103-112.
45. Tauszig ME, Picker SM, Gathof BS. Platelet derived cytokine accumulation in platelet concentrates treated for pathogen reduction. Transfus Apher Sci 2012; 46: 33-37.
46. Picker SM, Tauszig ME, Gathof BS. Cell quality of apheresis-derived platelets treated with riboflavin-ultraviolet light after resuspension in platelet additive solution. Transfusion 2012; 52: 510-516.
47. Seghatchian J, Hervit T, Putter JS. Effect of pathogen inactivation on the storage lesion in red cells and platelet concentrates. Transfus Apher Sci 2011; 45: 75-84.
48. Jy W, Ricci M, Shariatmadar S, et al. Microparticles in stored red blood cells as potential mediators of transfusion complications. Transfusion 2011; 51: 886-893.
49. Van de Watering L. Red cell storage and prognosis. Vox Sanq 2011; 100: 36-45.